JIANGXI SANXIN MEDTEC CO.,LTD. Jiangxi Sanxin Medtec Co.,Ltd. Stock
Equities
300453
CNE100001ZJ1
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.96 CNY | -1.85% |
|
+1.66% | +4.33% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 1.34B 185M | Sales 2023 | 1.3B 180M | Capitalization | 3.96B 549M |
|---|---|---|---|---|---|
| Net income 2022 | 185M 25.61M | Net income 2023 | 207M 28.65M | EV / Sales 2022 | 2.39 x |
| Net cash position 2022 | 232M 32.1M | Net cash position 2023 | 160M 22.1M | EV / Sales 2023 | 2.93 x |
| P/E ratio 2022 |
18.5
x | P/E ratio 2023 |
19.2
x | Employees | 1,927 |
| Yield 2022 |
1.74% | Yield 2023 |
1.51% | Free-Float | 53.87% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.85% | ||
| 1 week | +1.66% | ||
| Current month | +1.66% | ||
| 1 month | +2.45% | ||
| 3 months | +42.14% | ||
| 6 months | +2.98% | ||
| Current year | +4.33% |
1 week
7.78
8.21
1 month
7.098.21
Current year
4.888.21
1 year
4.888.21
3 years
4.8813.52
5 years
3.2813.95
10 years
2.5016.38
| Managers | Title | Age | Since |
|---|---|---|---|
Bei Ting Zou
DFI | Director of Finance/CFO | 38 | 19-08-31 |
Zhi Ping Mao
PSD | President | 50 | 03-11-30 |
Yi Xing Peng
CHM | Chairman | 66 | 97-03-06 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Lin Zhang
BRD | Director/Board Member | 41 | 01-12-31 |
Yi Xing Peng
CHM | Chairman | 66 | 97-03-06 |
Feng Lian Lei
BRD | Director/Board Member | 63 | 97-03-06 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.08% | 12 M€ | -16.71% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-10 | 7.96 | -1.85% | 5,226,200 |
| 24-05-09 | 8.11 | +1.63% | 5,607,808 |
| 24-05-08 | 7.98 | -0.87% | 5,262,370 |
| 24-05-07 | 8.05 | +3.07% | 9,731,187 |
End-of-day quote Shenzhen S.E., May 09, 2024
More quotes
Jiang Xi Sanxin Medtec Co., Ltd. is a China-based company principally engaged in research, development, manufacture and sales of disposable sterile injection medical devices. The Company's products include five series: syringe series, infusion & transfusion series, catheter tubing series, blood purification series and other series. The Company distributes its products within the domestic markets and to overseas markets.
Calendar
2024-08-29
- Q2 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +4.33% | 563M | |
| -4.84% | 182B | |
| +0.56% | 110B | |
| -3.35% | 68.11B | |
| +2.39% | 50.53B | |
| +9.36% | 44.8B | |
| +2.70% | 40.7B | |
| +3.43% | 26.53B | |
| +13.67% | 25.02B | |
| -0.32% | 24.96B |
- Stock Market
- Equities
- 300453 Stock